about
Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantationPerivascular stromal cells as a potential reservoir of human cytomegalovirus.Frequent occult infection with Cytomegalovirus in cardiac transplant recipients despite antiviral prophylaxisEarly cardiac allograft vasculopathy: are the viruses to blame?Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infectionRecombinant adenoviral gene transfer does not affect cardiac allograft vasculopathyLatent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients.Cytomegalovirus in transplantation - challenging the status quo.Development of breeding populations of rhesus macaques (Macaca mulatta) that are specific pathogen-free for rhesus cytomegalovirus.Should we consider patients with coexistent hepatitis B or C infection for orthotopic heart transplantation?Early cytomegalovirus-specific T-cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation.Risk factors of cardiac allograft vasculopathy.Human cytomegalovirus infection leads to elevated levels of transplant arteriosclerosis in a humanized mouse aortic xenograft model.MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS.Courage and character, leaders and legends: an interview with Hannah Valantine, MD.
P2860
Q26826856-55E2AC9C-7100-404F-99F8-AC4E543F7356Q33714313-F83FB273-95CA-44D1-9AA1-FBEA982C8958Q35914030-F827DFC3-6247-407E-A477-9266016D489CQ36014749-B9EA33F9-F138-41E0-8D66-5ACB033AC550Q36023008-4E530F56-9505-40F6-8493-5A5E500F80B7Q36335977-8A7FB654-EF95-46C3-898A-D15963A57E49Q36516318-178286AF-60C3-45DF-9B13-74BE5CF6E02FQ36787493-2C45DFD4-67AC-444B-9E5E-658C4422DF53Q37243861-57E42B98-BAC0-46DF-BA24-F5AFE36C4A75Q37338207-1158B97D-6C17-4E55-8FD7-DFED5C16295EQ40791125-70A2B475-92E9-43C1-85B7-5B6AF105AD24Q40800486-BEBE01A4-D207-487C-9F1B-57108471CFD0Q45190392-959A913D-91B0-4626-96E9-44A0C35EE044Q45921109-47EC3EF9-9792-42C6-A55E-8677B804D7BEQ48459844-F5373A54-2697-4956-9A5B-B784D42142E4
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The role of viruses in cardiac allograft vasculopathy.
@ast
The role of viruses in cardiac allograft vasculopathy.
@en
type
label
The role of viruses in cardiac allograft vasculopathy.
@ast
The role of viruses in cardiac allograft vasculopathy.
@en
prefLabel
The role of viruses in cardiac allograft vasculopathy.
@ast
The role of viruses in cardiac allograft vasculopathy.
@en
P2860
P1476
The role of viruses in cardiac allograft vasculopathy.
@en
P2093
Hannah A Valantine
P2860
P304
P356
10.1046/J.1600-6143.2003.00316.X
P407
P577
2004-02-01T00:00:00Z